Search - tctmd.com

Displaying 461 - 480 of 498

Sort: Relevancy | Date

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

November 10, 2011

News Industry News

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

November 08, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

News Daily News

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

L.A. McKeown

October 28, 2011

News Daily News

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Yael L. Maxwell

October 27, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Daily News

Study Proposes New CK-MB Threshold for Periprocedural MI

Caitlin E. Cox

October 12, 2011

News Daily News

Coronary CTA Use in Emergency Department Saves Time, Money

Jason Kahn

September 19, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Daily News

Study Quantifies Learning Curve for Radial PCI

August 10, 2011

News Daily News

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

Leah Lawrence

August 09, 2011

News Daily News

High Homocysteine Levels Linked with Contrast Nephropathy

Jason Kahn

July 28, 2011

News Industry News

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

July 26, 2011

News Industry News

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

July 20, 2011

News Daily News

OAT Fails to Change Practice: No Decrease in Late PCI for Stable MI Patients

L.A. McKeown

July 12, 2011

News Daily News

Most Acute PCIs Justified, But Nonacute Procedures Called into Question

Caitlin E. Cox

July 06, 2011

News Industry News

Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data

June 29, 2011

Advertisement

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

Ongoing Trials Explore Potential Benefits of Transradial PCI

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

Study Proposes New CK-MB Threshold for Periprocedural MI

Coronary CTA Use in Emergency Department Saves Time, Money

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Study Quantifies Learning Curve for Radial PCI

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

High Homocysteine Levels Linked with Contrast Nephropathy

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

OAT Fails to Change Practice: No Decrease in Late PCI for Stable MI Patients

Most Acute PCIs Justified, But Nonacute Procedures Called into Question

Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content